Trial Profile
French National Longitudinal Prospective Follow-up of Children Born Small for Gestational Age and Treated With Norditropin SimpleXx (French Health Authorities Commitment)
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Growth disorders
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 12 Jun 2019 Status changed from active, no longer recruiting to completed.
- 23 Apr 2015 New trial record